Mupadolimab, a promising antibody, is gaining considerable focus within the research field due to its distinct mechanism of action. This CD73-blocking therapeutic specifically blocks CD73, an plasma molecule linked in https://bookmarklinking.com/story11460005/a-new-antibody-a-innovative-cd73-targeted-antibody-reveals-potential